Literature DB >> 34310650

Neuroinvasiveness of the MR766 strain of Zika virus in IFNAR-/- mice maps to prM residues conserved amongst African genotype viruses.

Eri Nakayama1,2, Fumihiro Kato1, Shigeru Tajima1, Shinya Ogawa3, Kexin Yan2, Kenta Takahashi4, Yuko Sato4, Tadaki Suzuki4, Yasuhiro Kawai5, Takuya Inagaki1, Satoshi Taniguchi1, Thuy T Le2, Bing Tang2, Natalie A Prow2,6, Akihiko Uda7, Takahiro Maeki1, Chang-Kweng Lim1, Alexander A Khromykh6,8, Andreas Suhrbier2,6, Masayuki Saijo1.   

Abstract

Zika virus (ZIKV) strains are classified into the African and Asian genotypes. The higher virulence of the African MR766 strain, which has been used extensively in ZIKV research, in adult IFNα/β receptor knockout (IFNAR-/-) mice is widely viewed as an artifact associated with mouse adaptation due to at least 146 passages in wild-type suckling mouse brains. To gain insights into the molecular determinants of MR766's virulence, a series of genes from MR766 were swapped with those from the Asian genotype PRVABC59 isolate, which is less virulent in IFNAR-/- mice. MR766 causes 100% lethal infection in IFNAR-/- mice, but when the prM gene of MR766 was replaced with that of PRVABC59, the chimera MR/PR(prM) showed 0% lethal infection. The reduced virulence was associated with reduced neuroinvasiveness, with MR766 brain titers ≈3 logs higher than those of MR/PR(prM) after subcutaneous infection, but was not significantly different in brain titers of MR766 and MR/PR(prM) after intracranial inoculation. MR/PR(prM) also showed reduced transcytosis when compared with MR766 in vitro. The high neuroinvasiveness of MR766 in IFNAR-/- mice could be linked to the 10 amino acids that differ between the prM proteins of MR766 and PRVABC59, with 5 of these changes affecting positive charge and hydrophobicity on the exposed surface of the prM protein. These 10 amino acids are highly conserved amongst African ZIKV isolates, irrespective of suckling mouse passage, arguing that the high virulence of MR766 in adult IFNAR-/- mice is not the result of mouse adaptation.

Entities:  

Year:  2021        PMID: 34310650     DOI: 10.1371/journal.ppat.1009788

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  144 in total

1.  Structure of the immature dengue virus at low pH primes proteolytic maturation.

Authors:  I-Mei Yu; Wei Zhang; Heather A Holdaway; Long Li; Victor A Kostyuchenko; Paul R Chipman; Richard J Kuhn; Michael G Rossmann; Jue Chen
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

2.  Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres.

Authors:  Pavel Plevka; Anthony J Battisti; Jiraphan Junjhon; Dennis C Winkler; Heather A Holdaway; Poonsook Keelapang; Nopporn Sittisombut; Richard J Kuhn; Alasdair C Steven; Michael G Rossmann
Journal:  EMBO Rep       Date:  2011-05-13       Impact factor: 8.807

3.  Resuscitating mutations in a furin cleavage-deficient mutant of the flavivirus tick-borne encephalitis virus.

Authors:  Sigrid Elshuber; Christian W Mandl
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.

Authors:  W M Pardridge; D Triguero; J Buciak; J Yang
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

5.  Understanding How Zika Virus Enters and Infects Neural Target Cells.

Authors:  Jonathan J Miner; Michael S Diamond
Journal:  Cell Stem Cell       Date:  2016-05-05       Impact factor: 24.633

6.  Zika virus cell tropism in the developing human brain and inhibition by azithromycin.

Authors:  Hanna Retallack; Elizabeth Di Lullo; Carolina Arias; Kristeene A Knopp; Matthew T Laurie; Carmen Sandoval-Espinosa; Walter R Mancia Leon; Robert Krencik; Erik M Ullian; Julien Spatazza; Alex A Pollen; Caleigh Mandel-Brehm; Tomasz J Nowakowski; Arnold R Kriegstein; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-29       Impact factor: 11.205

Review 7.  Active targeting of brain tumors using nanocarriers.

Authors:  Arnaud Béduneau; Patrick Saulnier; Jean-Pierre Benoit
Journal:  Biomaterials       Date:  2007-08-22       Impact factor: 12.479

8.  Spontaneous Abortion Associated with Zika Virus Infection and Persistent Viremia.

Authors:  Anna Goncé; Miguel J Martínez; Elena Marbán-Castro; Adela Saco; Anna Soler; Maria Isabel Alvarez-Mora; Aida Peiro; Verónica Gonzalo; Gillian Hale; Julu Bhatnagar; Marta López; Sherif Zaki; Jaume Ordi; Azucena Bardají
Journal:  Emerg Infect Dis       Date:  2018-05       Impact factor: 6.883

9.  Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles.

Authors:  Liqin Jiang; Xuemin Li; Lingrong Liu; Qiqing Zhang
Journal:  Int J Nanomedicine       Date:  2013-05-08

10.  Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals.

Authors:  Brian P Daniels; David W Holman; Lillian Cruz-Orengo; Harsha Jujjavarapu; Douglas M Durrant; Robyn S Klein
Journal:  MBio       Date:  2014-08-26       Impact factor: 7.867

View more
  6 in total

Review 1.  Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy.

Authors:  Li Yin Tan; Thamil Vaani Komarasamy; William James; Vinod R M T Balasubramaniam
Journal:  Front Microbiol       Date:  2022-03-04       Impact factor: 5.640

2.  A Reverse Mutation E143K within the PrM Protein of Zika Virus Asian Lineage Natal RGN Strain Increases Infectivity and Cytopathicity.

Authors:  Chen-Sheng Lin; Wei-Jing Li; Chih-Yi Liao; Ju-Ying Kan; Szu-Hao Kung; Su-Hua Huang; Hsueh-Chou Lai; Cheng-Wen Lin
Journal:  Viruses       Date:  2022-07-20       Impact factor: 5.818

3.  The Chimeric Binjari-Zika Vaccine Provides Long-Term Protection against ZIKA Virus Challenge.

Authors:  Jessamine E Hazlewood; Bing Tang; Kexin Yan; Daniel J Rawle; Jessica J Harrison; Roy A Hall; Jody Hobson-Peters; Andreas Suhrbier
Journal:  Vaccines (Basel)       Date:  2022-01-06

4.  Leu-to-Phe substitution at prM146 decreases the growth ability of Zika virus and partially reduces its pathogenicity in mice.

Authors:  Takuya Inagaki; Satoshi Taniguchi; Yasuhiro Kawai; Takahiro Maeki; Eri Nakayama; Shigeru Tajima; Haruko Takeyama; Chang Kweng Lim; Masayuki Saijo
Journal:  Sci Rep       Date:  2021-10-04       Impact factor: 4.379

5.  Embryonic Stage of Congenital Zika Virus Infection Determines Fetal and Postnatal Outcomes in Mice.

Authors:  Eri Nakayama; Yasuhiro Kawai; Satoshi Taniguchi; Jessamine E Hazlewood; Ken-Ichi Shibasaki; Kenta Takahashi; Yuko Sato; Bing Tang; Kexin Yan; Naoko Katsuta; Shigeru Tajima; Chang Kweng Lim; Tadaki Suzuki; Andreas Suhrbier; Masayuki Saijo
Journal:  Viruses       Date:  2021-09-11       Impact factor: 5.048

6.  Zika M-A Potential Viroporin: Mutational Study and Drug Repurposing.

Authors:  Prabhat Pratap Singh Tomar; Miriam Krugliak; Anamika Singh; Isaiah T Arkin
Journal:  Biomedicines       Date:  2022-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.